摘要

This study evaluated the inhibitory effects of different extracts and fractions fromEucalyptus. grandis x urophylla bark (EB) against alpha-glucosidase and alpha-amylase enzyme activities. The ethyl acetate extract (EB-E) showed the highest activity among others. Seven fractions were derived from EB-E; among them EB-E-7 showed the highest significant inhibition of both enzymes, with IC50 of 1.40 +/- 0.18 and 1.72 +/- 0.12 mu g/mL, respectively. EB-E and its active fraction EB-E-7 showed highest contents of total phenolics: 178.79 +/- 4.68 and 920.4 +/- 5.46 mgGAE(a)g(-1), respectively. HPLC-MS analysis of EB-E-7 revealed the presence of ellagic acid, quercetin-glucuronide, quercetin-3- alpha-rhamnopyranoside, and ellagic acid rhamnoside as major compounds, together with smaller concentrations of myricetin-rhamnoside, isorhamnetin-hexoside, myricetin-3-alpha-arabinofuranoside, and isorhamnetin. Therefore, the phenolic compounds from Eucalyptus grandis x E. urograndis bark potently inhibited alpha-amylase and alpha-glucosidase activity, having potential in prevention of hyperglycemia.